Accessibility Menu
Theralase Technologies logo

Theralase Technologies

(OTC) TLTFF

Current Price$0.17
Market Cap$43.11M
Since IPO (2012)-10%
5 Year-25%
1 Year+22%
1 Month-9%

Theralase Technologies Financials at a Glance

Market Cap

$43.11M

Revenue (TTM)

CA$858.25K

Net Income (TTM)

-CA$3.68M

EPS (TTM)

-$0.01

P/E Ratio

-16.12

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$0.17

Volume

26,962

Open

$0.17

Previous Close

$0.17

Daily Range

$0.17 - $0.17

52-Week Range

$0.10 - $0.31

Estimated Earnings Date

Aug 26, 2026

TLTFF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Theralase Technologies

Industry

Healthcare Equipment and Supplies

Employees

16

CEO

Roger J. Dumoulin-White

Headquarters

Toronto, ON M4B 3G4, CA

TLTFF Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

-247%

Return on Capital

-2%

Return on Assets

-95%

Earnings Yield

-6.20%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$43.11M

Shares Outstanding

257.06M

Volume

26.96K

Avg. Volume

187.51K

Financials (TTM)

Gross Profit

CA$507.13K

Operating Income

-CA$4.18M

EBITDA

-CA$3.81M

Operating Cash Flow

-CA$3.29M

Capital Expenditure

-CA$48.94K

Free Cash Flow

-CA$3.33M

Cash & ST Invst.

CA$182.91K

Total Debt

CA$458.05K

Theralase Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$132.98K

+45.8%

Gross Profit

CA$5.13K

-61.4%

Gross Margin

3.86%

N/A

Market Cap

$43.11M

N/A

Market Cap/Employee

$3.08M

N/A

Employees

14

N/A

Net Income

-CA$1.03M

+29.7%

EBITDA

-CA$973.67K

+30.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$1.01M

+663.9%

Total Debt

CA$432.70K

+60.5%

Accounts Receivable

CA$855.73K

+27.8%

Inventory

CA$486.77K

-5.5%

Long Term Debt

CA$93.66K

-43.9%

Short Term Debt

CA$338.16K

+229.4%

Return on Assets

-94.63%

N/A

Return on Invested Capital

-1.82%

N/A

Free Cash Flow

-CA$246.07K

+40.3%

Operating Cash Flow

-CA$245.17K

+29.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDDVFMedical Developments International Limited
$0.37+0.00%
SEOVFSernova Corp.
$0.11+0.00%
RDGLVivos Inc.
$0.07+1.56%
BIOQBioqual, Inc.
$32.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About TLTFF

What is the current price of Theralase Technologies?

Theralase Technologies is trading at $0.17 per share.

What is the 52-week range for Theralase Technologies?

Over the past 52 weeks, Theralase Technologies has traded between $0.10 and $0.31.

How much debt does Theralase Technologies have?

As of the most recent reporting period, Theralase Technologies reported total debt of CA$309.26K.

How much cash does Theralase Technologies have on hand?

Theralase Technologies reported CA$719.39K in cash and cash equivalents in its most recent financial results.

What is Theralase Technologies’s dividend yield?

Theralase Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.